Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body's immune system to attack tumours.

The global Cancer Immunotherapies market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cancer Immunotherapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Cancer Immunotherapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Cancer Immunotherapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Cancer Immunotherapies include Amgen, AstraZeneca, Roche, Bristol-Myers Squibb, Bayer, Merck, ARMO BioSciences (Eli Lilly), Novartis and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Cancer Immunotherapies, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Cancer Immunotherapies, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cancer Immunotherapies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Immunotherapies sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Immunotherapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cancer Immunotherapies sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Cancer Immunotherapies Market Report

Report Metric	Details
Report Name	Cancer Immunotherapies Market
Segment by Type	Monoclonal Antibodies (MABs) Cancer Vaccines Immunomodulators Adoptive Cell transfer Checkpoint Inhibitors
Segment by Application	Breast Cancer Leukemia Lymphoma Melanoma Colorectal Cancer Non-Small Cell Lung Cancer
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Bristol-Myers Squibb, Bayer, Merck, ARMO BioSciences (Eli Lilly), Novartis, Pfizer, Johnson & Johnson, AbbVie, Gilead Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Cancer Immunotherapies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Cancer Immunotherapies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Immunotherapies sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Immunotherapies Market report?

Ans: The main players in the Cancer Immunotherapies Market are Roche, Bristol-Myers Squibb, Bayer, Merck, ARMO BioSciences (Eli Lilly), Novartis, Pfizer, Johnson & Johnson, AbbVie, Gilead Sciences

What are the Application segmentation covered in the Cancer Immunotherapies Market report?

Ans: The Applications covered in the Cancer Immunotherapies Market report are Breast Cancer, Leukemia, Lymphoma, Melanoma, Colorectal Cancer, Non-Small Cell Lung Cancer

What are the Type segmentation covered in the Cancer Immunotherapies Market report?

Ans: The Types covered in the Cancer Immunotherapies Market report are Monoclonal Antibodies (MABs), Cancer Vaccines, Immunomodulators, Adoptive Cell transfer, Checkpoint Inhibitors

1 Study Coverage

1.1 Cancer Immunotherapies Product Introduction

1.2 Market by Type

1.2.1 Global Cancer Immunotherapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies (MABs)

1.2.3 Cancer Vaccines

1.2.4 Immunomodulators

1.2.5 Adoptive Cell transfer

1.2.6 Checkpoint Inhibitors

1.3 Market by Application

1.3.1 Global Cancer Immunotherapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Leukemia

1.3.4 Lymphoma

1.3.5 Melanoma

1.3.6 Colorectal Cancer

1.3.7 Non-Small Cell Lung Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Cancer Immunotherapies Sales Estimates and Forecasts 2019-2030

2.2 Global Cancer Immunotherapies Revenue by Region

2.2.1 Global Cancer Immunotherapies Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Cancer Immunotherapies Revenue by Region (2019-2024)

2.2.3 Global Cancer Immunotherapies Revenue by Region (2025-2030)

2.2.4 Global Cancer Immunotherapies Revenue Market Share by Region (2019-2030)

2.3 Global Cancer Immunotherapies Sales Estimates and Forecasts 2019-2030

2.4 Global Cancer Immunotherapies Sales by Region

2.4.1 Global Cancer Immunotherapies Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Cancer Immunotherapies Sales by Region (2019-2024)

2.4.3 Global Cancer Immunotherapies Sales by Region (2025-2030)

2.4.4 Global Cancer Immunotherapies Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Cancer Immunotherapies Sales by Manufacturers

3.1.1 Global Cancer Immunotherapies Sales by Manufacturers (2019-2024)

3.1.2 Global Cancer Immunotherapies Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Immunotherapies in 2023

3.2 Global Cancer Immunotherapies Revenue by Manufacturers

3.2.1 Global Cancer Immunotherapies Revenue by Manufacturers (2019-2024)

3.2.2 Global Cancer Immunotherapies Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Cancer Immunotherapies Revenue in 2023

3.3 Global Key Players of Cancer Immunotherapies, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Cancer Immunotherapies Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Cancer Immunotherapies, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Cancer Immunotherapies, Product Offered and Application

3.8 Global Key Manufacturers of Cancer Immunotherapies, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Cancer Immunotherapies Sales by Type

4.1.1 Global Cancer Immunotherapies Historical Sales by Type (2019-2024)

4.1.2 Global Cancer Immunotherapies Forecasted Sales by Type (2025-2030)

4.1.3 Global Cancer Immunotherapies Sales Market Share by Type (2019-2030)

4.2 Global Cancer Immunotherapies Revenue by Type

4.2.1 Global Cancer Immunotherapies Historical Revenue by Type (2019-2024)

4.2.2 Global Cancer Immunotherapies Forecasted Revenue by Type (2025-2030)

4.2.3 Global Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

4.3 Global Cancer Immunotherapies Price by Type

4.3.1 Global Cancer Immunotherapies Price by Type (2019-2024)

4.3.2 Global Cancer Immunotherapies Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Cancer Immunotherapies Sales by Application

5.1.1 Global Cancer Immunotherapies Historical Sales by Application (2019-2024)

5.1.2 Global Cancer Immunotherapies Forecasted Sales by Application (2025-2030)

5.1.3 Global Cancer Immunotherapies Sales Market Share by Application (2019-2030)

5.2 Global Cancer Immunotherapies Revenue by Application

5.2.1 Global Cancer Immunotherapies Historical Revenue by Application (2019-2024)

5.2.2 Global Cancer Immunotherapies Forecasted Revenue by Application (2025-2030)

5.2.3 Global Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

5.3 Global Cancer Immunotherapies Price by Application

5.3.1 Global Cancer Immunotherapies Price by Application (2019-2024)

5.3.2 Global Cancer Immunotherapies Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Cancer Immunotherapies Market Size by Type

6.1.1 US & Canada Cancer Immunotherapies Sales by Type (2019-2030)

6.1.2 US & Canada Cancer Immunotherapies Revenue by Type (2019-2030)

6.2 US & Canada Cancer Immunotherapies Market Size by Application

6.2.1 US & Canada Cancer Immunotherapies Sales by Application (2019-2030)

6.2.2 US & Canada Cancer Immunotherapies Revenue by Application (2019-2030)

6.3 US & Canada Cancer Immunotherapies Market Size by Country

6.3.1 US & Canada Cancer Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Cancer Immunotherapies Sales by Country (2019-2030)

6.3.3 US & Canada Cancer Immunotherapies Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Cancer Immunotherapies Market Size by Type

7.1.1 Europe Cancer Immunotherapies Sales by Type (2019-2030)

7.1.2 Europe Cancer Immunotherapies Revenue by Type (2019-2030)

7.2 Europe Cancer Immunotherapies Market Size by Application

7.2.1 Europe Cancer Immunotherapies Sales by Application (2019-2030)

7.2.2 Europe Cancer Immunotherapies Revenue by Application (2019-2030)

7.3 Europe Cancer Immunotherapies Market Size by Country

7.3.1 Europe Cancer Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Cancer Immunotherapies Sales by Country (2019-2030)

7.3.3 Europe Cancer Immunotherapies Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Cancer Immunotherapies Market Size

8.1.1 China Cancer Immunotherapies Sales (2019-2030)

8.1.2 China Cancer Immunotherapies Revenue (2019-2030)

8.2 China Cancer Immunotherapies Market Size by Application

8.2.1 China Cancer Immunotherapies Sales by Application (2019-2030)

8.2.2 China Cancer Immunotherapies Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Cancer Immunotherapies Market Size by Type

9.1.1 Asia Cancer Immunotherapies Sales by Type (2019-2030)

9.1.2 Asia Cancer Immunotherapies Revenue by Type (2019-2030)

9.2 Asia Cancer Immunotherapies Market Size by Application

9.2.1 Asia Cancer Immunotherapies Sales by Application (2019-2030)

9.2.2 Asia Cancer Immunotherapies Revenue by Application (2019-2030)

9.3 Asia Cancer Immunotherapies Sales by Region

9.3.1 Asia Cancer Immunotherapies Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Cancer Immunotherapies Revenue by Region (2019-2030)

9.3.3 Asia Cancer Immunotherapies Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Cancer Immunotherapies Market Size by Type

10.1.1 Middle East, Africa and Latin America Cancer Immunotherapies Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Cancer Immunotherapies Market Size by Application

10.2.1 Middle East, Africa and Latin America Cancer Immunotherapies Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Cancer Immunotherapies Sales by Country

10.3.1 Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Cancer Immunotherapies Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Overview

11.1.3 Amgen Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Amgen Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Amgen Recent Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Information

11.2.2 AstraZeneca Overview

11.2.3 AstraZeneca Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 AstraZeneca Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AstraZeneca Recent Developments

11.3 Roche

11.3.1 Roche Company Information

11.3.2 Roche Overview

11.3.3 Roche Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Roche Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Roche Recent Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Information

11.4.2 Bristol-Myers Squibb Overview

11.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Bristol-Myers Squibb Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Bristol-Myers Squibb Recent Developments

11.5 Bayer

11.5.1 Bayer Company Information

11.5.2 Bayer Overview

11.5.3 Bayer Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Bayer Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Bayer Recent Developments

11.6 Merck

11.6.1 Merck Company Information

11.6.2 Merck Overview

11.6.3 Merck Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Merck Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Merck Recent Developments

11.7 ARMO BioSciences (Eli Lilly)

11.7.1 ARMO BioSciences (Eli Lilly) Company Information

11.7.2 ARMO BioSciences (Eli Lilly) Overview

11.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 ARMO BioSciences (Eli Lilly) Recent Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Overview

11.8.3 Novartis Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Novartis Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Novartis Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Information

11.9.2 Pfizer Overview

11.9.3 Pfizer Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Pfizer Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Pfizer Recent Developments

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Information

11.10.2 Johnson & Johnson Overview

11.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Johnson & Johnson Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Johnson & Johnson Recent Developments

11.11 AbbVie

11.11.1 AbbVie Company Information

11.11.2 AbbVie Overview

11.11.3 AbbVie Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 AbbVie Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 AbbVie Recent Developments

11.12 Gilead Sciences

11.12.1 Gilead Sciences Company Information

11.12.2 Gilead Sciences Overview

11.12.3 Gilead Sciences Cancer Immunotherapies Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Gilead Sciences Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Gilead Sciences Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Cancer Immunotherapies Industry Chain Analysis

12.2 Cancer Immunotherapies Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Cancer Immunotherapies Production Mode & Process

12.4 Cancer Immunotherapies Sales and Marketing

12.4.1 Cancer Immunotherapies Sales Channels

12.4.2 Cancer Immunotherapies Distributors

12.5 Cancer Immunotherapies Customers

13 Market Dynamics

13.1 Cancer Immunotherapies Industry Trends

13.2 Cancer Immunotherapies Market Drivers

13.3 Cancer Immunotherapies Market Challenges

13.4 Cancer Immunotherapies Market Restraints

14 Key Findings in The Global Cancer Immunotherapies Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

ARMO BioSciences (Eli Lilly)

List of Tables

Table 1. Global Cancer Immunotherapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Monoclonal Antibodies (MABs)

Table 3. Major Manufacturers of Cancer Vaccines

Table 4. Major Manufacturers of Immunomodulators

Table 5. Major Manufacturers of Adoptive Cell transfer

Table 6. Major Manufacturers of Checkpoint Inhibitors

Table 7. Global Cancer Immunotherapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Cancer Immunotherapies Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Cancer Immunotherapies Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Cancer Immunotherapies Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Cancer Immunotherapies Revenue Market Share by Region (2019-2024)

Table 12. Global Cancer Immunotherapies Revenue Market Share by Region (2025-2030)

Table 13. Global Cancer Immunotherapies Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Cancer Immunotherapies Sales by Region (2019-2024) & (K Units)

Table 15. Global Cancer Immunotherapies Sales by Region (2025-2030) & (K Units)

Table 16. Global Cancer Immunotherapies Sales Market Share by Region (2019-2024)

Table 17. Global Cancer Immunotherapies Sales Market Share by Region (2025-2030)

Table 18. Global Cancer Immunotherapies Sales by Manufacturers (2019-2024) & (K Units)

Table 19. Global Cancer Immunotherapies Sales Share by Manufacturers (2019-2024)

Table 20. Global Cancer Immunotherapies Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Cancer Immunotherapies Revenue Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Cancer Immunotherapies, Industry Ranking, 2022 VS 2023 VS 2024

Table 23. Cancer Immunotherapies Price by Manufacturers 2019-2024 (USD/Unit)

Table 24. Global Cancer Immunotherapies Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Cancer Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapies as of 2023)

Table 26. Global Key Manufacturers of Cancer Immunotherapies, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Cancer Immunotherapies, Product Offered and Application

Table 28. Global Key Manufacturers of Cancer Immunotherapies, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 31. Global Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 32. Global Cancer Immunotherapies Sales Share by Type (2019-2024)

Table 33. Global Cancer Immunotherapies Sales Share by Type (2025-2030)

Table 34. Global Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Cancer Immunotherapies Revenue Share by Type (2019-2024)

Table 37. Global Cancer Immunotherapies Revenue Share by Type (2025-2030)

Table 38. Cancer Immunotherapies Price by Type (2019-2024) & (USD/Unit)

Table 39. Global Cancer Immunotherapies Price Forecast by Type (2025-2030) & (USD/Unit)

Table 40. Global Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 41. Global Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 42. Global Cancer Immunotherapies Sales Share by Application (2019-2024)

Table 43. Global Cancer Immunotherapies Sales Share by Application (2025-2030)

Table 44. Global Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Cancer Immunotherapies Revenue Share by Application (2019-2024)

Table 47. Global Cancer Immunotherapies Revenue Share by Application (2025-2030)

Table 48. Cancer Immunotherapies Price by Application (2019-2024) & (USD/Unit)

Table 49. Global Cancer Immunotherapies Price Forecast by Application (2025-2030) & (USD/Unit)

Table 50. US & Canada Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 51. US & Canada Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 52. US & Canada Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 55. US & Canada Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 56. US & Canada Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Cancer Immunotherapies Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Cancer Immunotherapies Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Cancer Immunotherapies Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Cancer Immunotherapies Sales by Country (2019-2024) & (K Units)

Table 62. US & Canada Cancer Immunotherapies Sales by Country (2025-2030) & (K Units)

Table 63. Europe Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 64. Europe Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 65. Europe Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 68. Europe Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 69. Europe Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Cancer Immunotherapies Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Cancer Immunotherapies Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Cancer Immunotherapies Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Cancer Immunotherapies Sales by Country (2019-2024) & (K Units)

Table 75. Europe Cancer Immunotherapies Sales by Country (2025-2030) & (K Units)

Table 76. China Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 77. China Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 78. China Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 81. China Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 82. China Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 85. Asia Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 86. Asia Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 89. Asia Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 90. Asia Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Cancer Immunotherapies Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Cancer Immunotherapies Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Cancer Immunotherapies Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Cancer Immunotherapies Sales by Region (2019-2024) & (K Units)

Table 96. Asia Cancer Immunotherapies Sales by Region (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Type (2019-2024) & (K Units)

Table 98. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Type (2025-2030) & (K Units)

Table 99. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Application (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Application (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Cancer Immunotherapies Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Cancer Immunotherapies Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Country (2019-2024) & (K Units)

Table 109. Middle East, Africa and Latin America Cancer Immunotherapies Sales by Country (2025-2030) & (K Units)

Table 110. Amgen Company Information

Table 111. Amgen Description and Major Businesses

Table 112. Amgen Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Amgen Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Amgen Recent Developments

Table 115. AstraZeneca Company Information

Table 116. AstraZeneca Description and Major Businesses

Table 117. AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. AstraZeneca Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. AstraZeneca Recent Developments

Table 120. Roche Company Information

Table 121. Roche Description and Major Businesses

Table 122. Roche Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Roche Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Roche Recent Developments

Table 125. Bristol-Myers Squibb Company Information

Table 126. Bristol-Myers Squibb Description and Major Businesses

Table 127. Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Bristol-Myers Squibb Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Bristol-Myers Squibb Recent Developments

Table 130. Bayer Company Information

Table 131. Bayer Description and Major Businesses

Table 132. Bayer Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Bayer Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Bayer Recent Developments

Table 135. Merck Company Information

Table 136. Merck Description and Major Businesses

Table 137. Merck Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Merck Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Merck Recent Developments

Table 140. ARMO BioSciences (Eli Lilly) Company Information

Table 141. ARMO BioSciences (Eli Lilly) Description and Major Businesses

Table 142. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. ARMO BioSciences (Eli Lilly) Recent Developments

Table 145. Novartis Company Information

Table 146. Novartis Description and Major Businesses

Table 147. Novartis Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. Novartis Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Novartis Recent Developments

Table 150. Pfizer Company Information

Table 151. Pfizer Description and Major Businesses

Table 152. Pfizer Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 153. Pfizer Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Pfizer Recent Developments

Table 155. Johnson & Johnson Company Information

Table 156. Johnson & Johnson Description and Major Businesses

Table 157. Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 158. Johnson & Johnson Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Johnson & Johnson Recent Developments

Table 160. AbbVie Company Information

Table 161. AbbVie Description and Major Businesses

Table 162. AbbVie Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 163. AbbVie Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. AbbVie Recent Developments

Table 165. Gilead Sciences Company Information

Table 166. Gilead Sciences Description and Major Businesses

Table 167. Gilead Sciences Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 168. Gilead Sciences Cancer Immunotherapies Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Gilead Sciences Recent Developments

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. Cancer Immunotherapies Distributors List

Table 173. Cancer Immunotherapies Customers List

Table 174. Cancer Immunotherapies Market Trends

Table 175. Cancer Immunotherapies Market Drivers

Table 176. Cancer Immunotherapies Market Challenges

Table 177. Cancer Immunotherapies Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. Cancer Immunotherapies Product Picture

Figure 2. Global Cancer Immunotherapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Cancer Immunotherapies Market Share by Type in 2023 & 2030

Figure 4. Monoclonal Antibodies (MABs) Product Picture

Figure 5. Cancer Vaccines Product Picture

Figure 6. Immunomodulators Product Picture

Figure 7. Adoptive Cell transfer Product Picture

Figure 8. Checkpoint Inhibitors Product Picture

Figure 9. Global Cancer Immunotherapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Cancer Immunotherapies Market Share by Application in 2023 & 2030

Figure 11. Breast Cancer

Figure 12. Leukemia

Figure 13. Lymphoma

Figure 14. Melanoma

Figure 15. Colorectal Cancer

Figure 16. Non-Small Cell Lung Cancer

Figure 17. Cancer Immunotherapies Report Years Considered

Figure 18. Global Cancer Immunotherapies Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Cancer Immunotherapies Revenue 2019-2030 (US$ Million)

Figure 20. Global Cancer Immunotherapies Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 21. Global Cancer Immunotherapies Revenue Market Share by Region (2019-2030)

Figure 22. Global Cancer Immunotherapies Sales 2019-2030 ((K Units)

Figure 23. Global Cancer Immunotherapies Sales Market Share by Region (2019-2030)

Figure 24. US & Canada Cancer Immunotherapies Sales YoY (2019-2030) & (K Units)

Figure 25. US & Canada Cancer Immunotherapies Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Europe Cancer Immunotherapies Sales YoY (2019-2030) & (K Units)

Figure 27. Europe Cancer Immunotherapies Revenue YoY (2019-2030) & (US$ Million)

Figure 28. China Cancer Immunotherapies Sales YoY (2019-2030) & (K Units)

Figure 29. China Cancer Immunotherapies Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Asia (excluding China) Cancer Immunotherapies Sales YoY (2019-2030) & (K Units)

Figure 31. Asia (excluding China) Cancer Immunotherapies Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Middle East, Africa and Latin America Cancer Immunotherapies Sales YoY (2019-2030) & (K Units)

Figure 33. Middle East, Africa and Latin America Cancer Immunotherapies Revenue YoY (2019-2030) & (US$ Million)

Figure 34. The Cancer Immunotherapies Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 35. The Top 5 and 10 Largest Manufacturers of Cancer Immunotherapies in the World: Market Share by Cancer Immunotherapies Revenue in 2023

Figure 36. Global Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 37. Global Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 38. Global Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 39. Global Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 40. Global Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 42. US & Canada Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 43. US & Canada Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 44. US & Canada Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 45. US & Canada Cancer Immunotherapies Revenue Share by Country (2019-2030)

Figure 46. US & Canada Cancer Immunotherapies Sales Share by Country (2019-2030)

Figure 47. U.S. Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 48. Canada Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 49. Europe Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 50. Europe Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 51. Europe Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 52. Europe Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 53. Europe Cancer Immunotherapies Revenue Share by Country (2019-2030)

Figure 54. Europe Cancer Immunotherapies Sales Share by Country (2019-2030)

Figure 55. Germany Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 56. France Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 57. U.K. Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 58. Italy Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 59. Russia Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 60. China Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 61. China Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 62. China Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 63. China Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 64. Asia Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 65. Asia Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 66. Asia Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 67. Asia Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 68. Asia Cancer Immunotherapies Revenue Share by Region (2019-2030)

Figure 69. Asia Cancer Immunotherapies Sales Share by Region (2019-2030)

Figure 70. Japan Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 71. South Korea Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 72. China Taiwan Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 73. Southeast Asia Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 74. India Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Cancer Immunotherapies Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Cancer Immunotherapies Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Cancer Immunotherapies Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Cancer Immunotherapies Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Cancer Immunotherapies Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Cancer Immunotherapies Sales Share by Country (2019-2030)

Figure 81. Brazil Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Cancer Immunotherapies Revenue (2019-2030) & (US$ Million)

Figure 86. Cancer Immunotherapies Value Chain

Figure 87. Cancer Immunotherapies Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Precision Cancer Imaging System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z10214

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Cryosurgical Equipment for Cancer Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39B12765

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Brachytherapy Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Q18678

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Gynecological Cancer Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30P10282

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions